Targeting lysosomes by design: novel N -acridine thiosemicarbazones that enable direct detection of intracellular drug localization and overcome P-glycoprotein (Pgp)-mediated resistance
Year: 2024
Type: article
Abstract: Inclusion of the acridine moiety into the thiosemicarbazone framework of NATs facilitates their function as lysosomotropic substrates for P-glycoprotein (Pgp). This promotes lysosomal targeting and effectively overcomes Pgp-mediated drug resistance.
Source: Chemical Science
DOI: 10.1039/d4sc04339a
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
Awards: G1468294473, G2337203496, Pharmaceutical Development of Innovative "Trojan Horse" Anti-Cancer Agents that Inhibit Desmoplasia by Reprogramming Signalling, To Biochemically Trick P-Glycoprotein (Pgp) to Target Resistance via Lysosomal Pgp, Novel Hormone Analogues as an Innovative Endocrinological Intervention for the Anaemia of Chronic Disease, G3094260312, Melanotransferrin: A “Missing Link” and a Novel Pharmacological Target for Treatment, Biomedical Investigations of Pharmacology and Pathology for Disease Treatment, The “New” Biochemistry of Polyamines: When Metabolic Pathways Collide, Hormone Transport by Alpha-2-Macroglobulin: Novel Roles in Regulating Hormone Activity, Pharmacological and Pharmaceutical Development of Novel Drugs for Multiple Major Disease States, G6657081448
OpenAlex ID: W4401611491
